NCT06902935

Brief Summary

Construct a breast cancer risk prediction model based on traditional Chinese medicine four diagnostic instruments and B-ultrasound images. Ensure that the key evaluation indicators of the model reach a high level through clinical verification, so as to contribute to accurate clinical diagnosis and treatment decision-making.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,500

participants targeted

Target at P75+ for all trials

Timeline
11mo left

Started Apr 2025

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress52%
Apr 2025Apr 2027

First Submitted

Initial submission to the registry

February 16, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 30, 2025

Completed
27 days until next milestone

Study Start

First participant enrolled

April 26, 2025

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 26, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 26, 2027

Last Updated

March 30, 2025

Status Verified

February 1, 2025

Enrollment Period

2 years

First QC Date

February 16, 2025

Last Update Submit

March 24, 2025

Conditions

Outcome Measures

Primary Outcomes (9)

  • Tongue appearance collection (overall tongue color)

    pale white, pale purple, light red, dark red, dark purple

    through study completion, an average of 1 year

  • Tongue appearance collection (overall tongue coating color)

    white, yellow, no tongue coating

    through study completion, an average of 1 year

  • Tongue appearance collection (thickness of the tongue coating)

    Thin tongue coating, thick tongue coating, scanty tongue coating or no tongue coating

    through study completion, an average of 1 year

  • Pulse condition collection (pulse strength)

    forceful, moderate, weak

    through study completion, an average of 1 year

  • Pulse condition collection (pulse rhythm)

    Regular, rapid intermittent pulse, slow intermittent pulse.

    through study completion, an average of 1 year

  • Pulse condition collection (pulse rate)

    Slow pulse, moderate pulse, normal pulse, rapid pulse, extremely rapid pulse.

    through study completion, an average of 1 year

  • Collection of facial appearances (overall facial complexion)

    Normal facial complexion, white complexion, yellow complexion, red complexion, cyan complexion, black complexion

    through study completion, an average of 1 year

  • Collection of facial appearances (overall luster)

    With luster, without luster

    through study completion, an average of 1 year

  • Judgment of Constitution Score

    Balanced constitution, Qi-deficiency constitution, Yang-deficiency constitution, Yin-deficiency constitution, Phlegm-dampness constitution, Damp-heat constitution, Blood-stasis constitution, Qi-stagnation constitution, Special constitution.

    through study completion, an average of 1 year

Study Arms (2)

Case group

The patients included in the group are those whose pathological results of breast masses are malignant.

Diagnostic Test: Diagnosis of Breast Cancer by Traditional Chinese Medicine Four Examinations

Control group

The patients included in this group are those whose pathological results of breast masses are benign.

Diagnostic Test: Ultrasound diagnosis of breast cancer

Interventions

The Daosheng TCM Four-Diagnostic Instrument (DS01-A) comprehensively collects patients' TCM four-diagnostic information, covering tongue (e.g., overall color, coating color/thickness/greasiness, tooth marks, etc.), pulse (e.g., position, force, rhythm, etc.), face (e.g., overall color, luster, lip color/dryness, etc.) and constitution scores (quantifying 9 constitutions via the TCM Constitution Classification Table).

Case group

Professional ultrasound physicians use B - ultrasound equipment of the same model to accurately collect detailed parameters of breast masses according to a standardized process. These parameters include shape (oval, round, irregular), orientation (parallel, non - parallel), margin (smooth, non - smooth, with non - smooth including blurred, angular, microlobulated, spiculated, etc.), echo pattern (anechoic, hyperechoic, complex cystic - solid echo, hypoechoic, isoechoic, heterogeneous echo), posterior echo characteristics (no change, enhancement, shadowing, mixed), calcification (microcalcification and coarse calcification within the mass, calcification outside the mass, intraductal), and vascular supply (no blood supply, internal blood supply, marginal blood supply), etc.

Control group

Eligibility Criteria

Age30 Years - 75 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with breast masses who come to the clinic for medical treatment

You may qualify if:

  • Female patients aged between 30 and 75.
  • Patients who have a mass detected by US examination, need to undergo surgery or needle biopsy, and obtain a definite pathological result.
  • Patients who have obtained complete identification results of tongue, pulse, face, and constitution through the traditional Chinese medicine four diagnostic instruments.

You may not qualify if:

  • \- 1. Patients with severe heart, liver, or kidney insufficiency, or other serious systemic diseases.
  • \. Patients with a history of other malignant tumors. 3. Cases with poor - quality B - ultrasound images. 4. Cases with an unclear pathological diagnosis. 5. Patients with obvious lesions on the face, in the oral cavity, or on the tongue that may affect the measurement results.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Taizhou Central Hospital (Affiliated Hospital of Taizhou University)

Taizhou, Zhejiang, 318000, China

Location

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Establishment and Clinical Application of Breast Cancer Risk Prediction Model Based on Traditional Chinese Medicine Four Diagnostic Instruments and Ultrasound

Study Record Dates

First Submitted

February 16, 2025

First Posted

March 30, 2025

Study Start

April 26, 2025

Primary Completion (Estimated)

April 26, 2027

Study Completion (Estimated)

April 26, 2027

Last Updated

March 30, 2025

Record last verified: 2025-02

Locations